Loading viewer...
investor_presentation
Format: PDF investor_presentation
IOL Chemicals and Pharmaceuticals Limited presented Q4 and FY23 financial results and business performance in May 2023. The presentation covers financial highlights, pharmaceutical API portfolio development, specialty chemicals growth, and future prospects across diversified revenue segments.
investor_presentation
24 Pages
Nomura Holdings
investor_presentation
Boyd Group